- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Five held on suspicion of planning attack on German Christmas market - 2Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother
- 3Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- 4Elvis Presley's Infamous Pantera Shooting
- 5New peace laureate: Iran's arrest of Mohammadi 'confession of fear'
- November Lease Deals for the 2025 Kia EV6 are Too Good to Pass Up
- Bayer reports positive results for blood thinner after 2023 setback
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- AstraZeneca to invest $2 billion as part of US manufacturing push
- Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
- Amazon sued over 'punitive' handling of employee absences
- Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- What you need to know about Trump accounts as Michael and Susan Dell donate $6 billion to the new early childhood investment program
- Top German court to rule on claims by Wirecard shareholders
